NCT00253032终止3 期
PRIMA Study: Pain Relief Investigation of NeuroModulation Therapy in an Adult Population: A Double Blind, Randomized, Multicenter, Placebo Controlled Trial.
Fralex Therapeutics0 个研究点开始时间: 2005年11月15日最近更新:
适应症
试验速览
- 阶段
- 3 期
- 状态
- 终止
- 发起方
研究概览
简要总结
The study is being performed to determine the efficacy and safety of Fralex Neuromodulation Therapy (F-NMT), delivered by the Fralex PRIMA device, in reducing chronic musculoskeletal pain.
研究设计
- 研究类型
- Interventional
入排标准
- 接受健康志愿者
- 否
入选标准
- 未提供
排除标准
- 未提供
研究者
相似试验
终止
3 期
Pain Relief Investigation of Neuromodulation Therapy in an Adult Fibromyalgia PopulationPainFibromyalgiaNCT00450905Fralex Therapeutics200
已完成
3 期
Efficacy and Safety of Ralfinamide in Patients With Chronic Neuropathic Low Back PainPainNCT01019824Newron Pharmaceuticals SPA411
尚未招募
不适用
NEUROMOdulation Pain Therapy in Combination With Intensive PhysiotherapySpinal CordNCT05544175Charles University, Czech Republic10
Unknown
不适用
The Effectiveness of Peripheral Magnetic Stimulation in Men With Lower Urinary Tract SymptomsBladder HypersensitivityNCT04807569Joint-Stock Company North-West Center for Evidence-Based Medicine, Russian Federation68
已完成
2 期
Neurotropin Treatment of FibromyalgiaFibromyalgiaNCT00366535National Institute of Nursing Research (NINR)56